The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Continuos Glucose Monitoring Market Research Report 2024
Synopsis
Continuous glucose monitoring (CGM) is a method used to monitor blood glucose levels continuously throughout the day and night. CGM systems consist of a sensor placed under the skin, which measures glucose levels and transmits data to a receiver or smartphone.
The global Continuos Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for continuous glucose monitoring is driven by the increasing adoption of CGM systems for improved diabetes management, especially in individuals with type 1 diabetes and insulin-dependent type 2 diabetes. Technological advancements in CGM sensors, such as improved accuracy and longer wear time, have also contributed to the market's growth.
This report aims to provide a comprehensive presentation of the global market for Continuos Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuos Glucose Monitoring.
Report Scope
The Continuos Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuos Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuos Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Yicheng
Acon
Medtrum Technologies
MicroTech Medical, Inc
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type
Retrospective CGM (r-CGM)
Real-time continuous glucose monitoring (RT-CGM)
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuos Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuos Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Continuous glucose monitoring (CGM) is a method used to monitor blood glucose levels continuously throughout the day and night. CGM systems consist of a sensor placed under the skin, which measures glucose levels and transmits data to a receiver or smartphone.
The global Continuos Glucose Monitoring market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The market for continuous glucose monitoring is driven by the increasing adoption of CGM systems for improved diabetes management, especially in individuals with type 1 diabetes and insulin-dependent type 2 diabetes. Technological advancements in CGM sensors, such as improved accuracy and longer wear time, have also contributed to the market's growth.
This report aims to provide a comprehensive presentation of the global market for Continuos Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuos Glucose Monitoring.
Report Scope
The Continuos Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Continuos Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Continuos Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
LifeScan
Abbott
Ascensia
ARKRAY
I-SENS
Omron
B. Braun
77 Elektronika
AgaMatrix
ALL Medicus
Terumo
Yicheng
Acon
Medtrum Technologies
MicroTech Medical, Inc
Sinocare
Hybio Pharmaceutical
Lepu Medical
Yuyue Medical
Segment by Type
Retrospective CGM (r-CGM)
Real-time continuous glucose monitoring (RT-CGM)
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Continuos Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Continuos Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Continuos Glucose Monitoring Market Overview
1.1 Product Overview and Scope of Continuos Glucose Monitoring
1.2 Continuos Glucose Monitoring Segment by Type
1.2.1 Global Continuos Glucose Monitoring Market Value Comparison by Type (2024-2030)
1.2.2 Retrospective CGM (r-CGM)
1.2.3 Real-time continuous glucose monitoring (RT-CGM)
1.3 Continuos Glucose Monitoring Segment by Application
1.3.1 Global Continuos Glucose Monitoring Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Continuos Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Continuos Glucose Monitoring Revenue 2019-2030
1.4.2 Global Continuos Glucose Monitoring Sales 2019-2030
1.4.3 Global Continuos Glucose Monitoring Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Continuos Glucose Monitoring Market Competition by Manufacturers
2.1 Global Continuos Glucose Monitoring Sales Market Share by Manufacturers (2019-2024)
2.2 Global Continuos Glucose Monitoring Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Continuos Glucose Monitoring Average Price by Manufacturers (2019-2024)
2.4 Global Continuos Glucose Monitoring Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Continuos Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Continuos Glucose Monitoring, Product Type & Application
2.7 Continuos Glucose Monitoring Market Competitive Situation and Trends
2.7.1 Continuos Glucose Monitoring Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Continuos Glucose Monitoring Players Market Share by Revenue
2.7.3 Global Continuos Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Continuos Glucose Monitoring Retrospective Market Scenario by Region
3.1 Global Continuos Glucose Monitoring Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Continuos Glucose Monitoring Global Continuos Glucose Monitoring Sales by Region: 2019-2030
3.2.1 Global Continuos Glucose Monitoring Sales by Region: 2019-2024
3.2.2 Global Continuos Glucose Monitoring Sales by Region: 2025-2030
3.3 Global Continuos Glucose Monitoring Global Continuos Glucose Monitoring Revenue by Region: 2019-2030
3.3.1 Global Continuos Glucose Monitoring Revenue by Region: 2019-2024
3.3.2 Global Continuos Glucose Monitoring Revenue by Region: 2025-2030
3.4 North America Continuos Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Continuos Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Continuos Glucose Monitoring Sales by Country (2019-2030)
3.4.3 North America Continuos Glucose Monitoring Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Continuos Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Continuos Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Continuos Glucose Monitoring Sales by Country (2019-2030)
3.5.3 Europe Continuos Glucose Monitoring Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Continuos Glucose Monitoring Market Facts & Figures by Country
3.6.1 Asia Pacific Continuos Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Continuos Glucose Monitoring Sales by Country (2019-2030)
3.6.3 Asia Pacific Continuos Glucose Monitoring Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Continuos Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Continuos Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Continuos Glucose Monitoring Sales by Country (2019-2030)
3.7.3 Latin America Continuos Glucose Monitoring Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Continuos Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Continuos Glucose Monitoring Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Continuos Glucose Monitoring Sales by Country (2019-2030)
3.8.3 Middle East and Africa Continuos Glucose Monitoring Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Continuos Glucose Monitoring Sales by Type (2019-2030)
4.1.1 Global Continuos Glucose Monitoring Sales by Type (2019-2024)
4.1.2 Global Continuos Glucose Monitoring Sales by Type (2025-2030)
4.1.3 Global Continuos Glucose Monitoring Sales Market Share by Type (2019-2030)
4.2 Global Continuos Glucose Monitoring Revenue by Type (2019-2030)
4.2.1 Global Continuos Glucose Monitoring Revenue by Type (2019-2024)
4.2.2 Global Continuos Glucose Monitoring Revenue by Type (2025-2030)
4.2.3 Global Continuos Glucose Monitoring Revenue Market Share by Type (2019-2030)
4.3 Global Continuos Glucose Monitoring Price by Type (2019-2030)
5 Segment by Application
5.1 Global Continuos Glucose Monitoring Sales by Application (2019-2030)
5.1.1 Global Continuos Glucose Monitoring Sales by Application (2019-2024)
5.1.2 Global Continuos Glucose Monitoring Sales by Application (2025-2030)
5.1.3 Global Continuos Glucose Monitoring Sales Market Share by Application (2019-2030)
5.2 Global Continuos Glucose Monitoring Revenue by Application (2019-2030)
5.2.1 Global Continuos Glucose Monitoring Revenue by Application (2019-2024)
5.2.2 Global Continuos Glucose Monitoring Revenue by Application (2025-2030)
5.2.3 Global Continuos Glucose Monitoring Revenue Market Share by Application (2019-2030)
5.3 Global Continuos Glucose Monitoring Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Continuos Glucose Monitoring Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 LifeScan
6.2.1 LifeScan Corporation Information
6.2.2 LifeScan Description and Business Overview
6.2.3 LifeScan Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.2.4 LifeScan Continuos Glucose Monitoring Product Portfolio
6.2.5 LifeScan Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Abbott Continuos Glucose Monitoring Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Ascensia
6.4.1 Ascensia Corporation Information
6.4.2 Ascensia Description and Business Overview
6.4.3 Ascensia Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ascensia Continuos Glucose Monitoring Product Portfolio
6.4.5 Ascensia Recent Developments/Updates
6.5 ARKRAY
6.5.1 ARKRAY Corporation Information
6.5.2 ARKRAY Description and Business Overview
6.5.3 ARKRAY Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.5.4 ARKRAY Continuos Glucose Monitoring Product Portfolio
6.5.5 ARKRAY Recent Developments/Updates
6.6 I-SENS
6.6.1 I-SENS Corporation Information
6.6.2 I-SENS Description and Business Overview
6.6.3 I-SENS Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.6.4 I-SENS Continuos Glucose Monitoring Product Portfolio
6.6.5 I-SENS Recent Developments/Updates
6.7 Omron
6.6.1 Omron Corporation Information
6.6.2 Omron Description and Business Overview
6.6.3 Omron Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Omron Continuos Glucose Monitoring Product Portfolio
6.7.5 Omron Recent Developments/Updates
6.8 B. Braun
6.8.1 B. Braun Corporation Information
6.8.2 B. Braun Description and Business Overview
6.8.3 B. Braun Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.8.4 B. Braun Continuos Glucose Monitoring Product Portfolio
6.8.5 B. Braun Recent Developments/Updates
6.9 77 Elektronika
6.9.1 77 Elektronika Corporation Information
6.9.2 77 Elektronika Description and Business Overview
6.9.3 77 Elektronika Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.9.4 77 Elektronika Continuos Glucose Monitoring Product Portfolio
6.9.5 77 Elektronika Recent Developments/Updates
6.10 AgaMatrix
6.10.1 AgaMatrix Corporation Information
6.10.2 AgaMatrix Description and Business Overview
6.10.3 AgaMatrix Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.10.4 AgaMatrix Continuos Glucose Monitoring Product Portfolio
6.10.5 AgaMatrix Recent Developments/Updates
6.11 ALL Medicus
6.11.1 ALL Medicus Corporation Information
6.11.2 ALL Medicus Continuos Glucose Monitoring Description and Business Overview
6.11.3 ALL Medicus Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ALL Medicus Continuos Glucose Monitoring Product Portfolio
6.11.5 ALL Medicus Recent Developments/Updates
6.12 Terumo
6.12.1 Terumo Corporation Information
6.12.2 Terumo Continuos Glucose Monitoring Description and Business Overview
6.12.3 Terumo Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Terumo Continuos Glucose Monitoring Product Portfolio
6.12.5 Terumo Recent Developments/Updates
6.13 Yicheng
6.13.1 Yicheng Corporation Information
6.13.2 Yicheng Continuos Glucose Monitoring Description and Business Overview
6.13.3 Yicheng Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Yicheng Continuos Glucose Monitoring Product Portfolio
6.13.5 Yicheng Recent Developments/Updates
6.14 Acon
6.14.1 Acon Corporation Information
6.14.2 Acon Continuos Glucose Monitoring Description and Business Overview
6.14.3 Acon Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Acon Continuos Glucose Monitoring Product Portfolio
6.14.5 Acon Recent Developments/Updates
6.15 Medtrum Technologies
6.15.1 Medtrum Technologies Corporation Information
6.15.2 Medtrum Technologies Continuos Glucose Monitoring Description and Business Overview
6.15.3 Medtrum Technologies Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Medtrum Technologies Continuos Glucose Monitoring Product Portfolio
6.15.5 Medtrum Technologies Recent Developments/Updates
6.16 MicroTech Medical, Inc
6.16.1 MicroTech Medical, Inc Corporation Information
6.16.2 MicroTech Medical, Inc Continuos Glucose Monitoring Description and Business Overview
6.16.3 MicroTech Medical, Inc Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.16.4 MicroTech Medical, Inc Continuos Glucose Monitoring Product Portfolio
6.16.5 MicroTech Medical, Inc Recent Developments/Updates
6.17 Sinocare
6.17.1 Sinocare Corporation Information
6.17.2 Sinocare Continuos Glucose Monitoring Description and Business Overview
6.17.3 Sinocare Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Sinocare Continuos Glucose Monitoring Product Portfolio
6.17.5 Sinocare Recent Developments/Updates
6.18 Hybio Pharmaceutical
6.18.1 Hybio Pharmaceutical Corporation Information
6.18.2 Hybio Pharmaceutical Continuos Glucose Monitoring Description and Business Overview
6.18.3 Hybio Pharmaceutical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Hybio Pharmaceutical Continuos Glucose Monitoring Product Portfolio
6.18.5 Hybio Pharmaceutical Recent Developments/Updates
6.19 Lepu Medical
6.19.1 Lepu Medical Corporation Information
6.19.2 Lepu Medical Continuos Glucose Monitoring Description and Business Overview
6.19.3 Lepu Medical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Lepu Medical Continuos Glucose Monitoring Product Portfolio
6.19.5 Lepu Medical Recent Developments/Updates
6.20 Yuyue Medical
6.20.1 Yuyue Medical Corporation Information
6.20.2 Yuyue Medical Continuos Glucose Monitoring Description and Business Overview
6.20.3 Yuyue Medical Continuos Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
6.20.4 Yuyue Medical Continuos Glucose Monitoring Product Portfolio
6.20.5 Yuyue Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Continuos Glucose Monitoring Industry Chain Analysis
7.2 Continuos Glucose Monitoring Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Continuos Glucose Monitoring Production Mode & Process
7.4 Continuos Glucose Monitoring Sales and Marketing
7.4.1 Continuos Glucose Monitoring Sales Channels
7.4.2 Continuos Glucose Monitoring Distributors
7.5 Continuos Glucose Monitoring Customers
8 Continuos Glucose Monitoring Market Dynamics
8.1 Continuos Glucose Monitoring Industry Trends
8.2 Continuos Glucose Monitoring Market Drivers
8.3 Continuos Glucose Monitoring Market Challenges
8.4 Continuos Glucose Monitoring Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
